Health Products

Archived – Qiangli Zhuanggutongbiling (originally named Fufang Zhuangguguanjiewan)

· Published by Health Canada · Official notice

Details

Alert type: Foreign Product Alert (FPA)
Category: Natural health products
Issue: Undeclared Substance, Unauthorized products, Product Safety
Audience: General Public
Department: Health Canada
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Images

Details

These products are not authorized for sale in Canada and have not been found in the Canadian marketplace, but it is possible they may have been brought into the country by travellers or purchased over the Internet.

Source of alert

Hong Kong Department of Health

Product name

Qiangli Zhuanggutongbiling (originally named Fufang Zhuangguguanjiewan)

Manufacturer / Place of origin

Unknown/Hong Kong

Product description

Qiangli Zhuanggutongbiling has reportedly been used for joint pain and stiffness. The blue and white capsules are packaged in white bottle with a yellow label.

Reason for warning

The Hong Kong Department of Health advised the public not to use the health product Qiangli Zhuanggutongbiling (originally named Fufang Zhuangguguanjiewan) because it was found to contain the prescription drugs prednisolone acetate, cortisone acetate, piroxicam, and diclofenac.

Prescription drugs should only be taken under the supervision of a health care professional.

Possible side effects

Consumers who use Qiangli Zhuanggutongbiling may experience adverse effects associated with diclofenac and piroxicam, two non-steroidal anti-inflammatory drugs used for pain relief. Adverse effects include gastrointestinal disorders and fluid retention. Use of diclofenac and piroxicam is not recommended for certain individuals, including those taking diuretics, acetaminophen, methotrexate (a drug used in cancer treatment), and anticoagulants (medications used to prevent blood clotting). Additionally, the combined use of diclofenac and steroid hormones may increase the risk of gastrointestinal bleeding and ulcers.

What you should do

Canadians who have this product are advised not to use it, and should consult with a health care professional if they have concerns about their health related to the use of this product.

Health Canada advises Canadians to contact the Health Products and Food Branch Inspectorate at 1-800-267-9675 if they find the product listed above in the Canadian marketplace.

Background

Drugs and natural health products that are authorized for sale in Canada will have either an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN) or a Homeopathic Medicine Number (DIN-HM) on the label. These numbers indicate that the products have been assessed by Health Canada for safety, effectiveness and quality.

As of the date of this posting, no adverse reactions suspected to be associated with the use of this product have been reported in Canada.

Report a health or safety concern

  • Call toll-free at 1-866-234-2345.
  • Visit Health Canada's Web page on Adverse Reaction Reporting for information on how to report online, by mail or by fax.

Media enquiries

Health Canada
613-957-2983

Public enquiries

613-957-2991
1-866-225-0709

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime